3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection

Details for Australian Patent Application No. 2005292162 (hide)

Owner Scynexis, Inc

Inventors Fliri, Hans Georg; Houck, David Renwick

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005292162

PCT Pub. Number WO2006/039668

Priority 60/615,152 01.10.04 US; 60/707,626 11.08.05 US

Filing date 30 September 2005

Wipo publication date 13 April 2006

Acceptance publication date 10 November 2011

International Classifications

C07K 7/64 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

26 April 2007 PCT application entered the National Phase

  PCT publication WO2006/039668 Priority application(s): WO2006/039668

10 November 2011 Application Accepted

  Published as AU-B-2005292162

8 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005292184-Morphine and morphine precursors

2005292152-Aryl nitrogen-containing bicyclic compounds and their use as kinase inhibitors